Human platelets possess an inducible and saturable receptor specific for fibrinogen

scientific article published on June 25, 1979

Human platelets possess an inducible and saturable receptor specific for fibrinogen is …
instance of (P31):
scholarly articleQ13442814

External links are
P953full work available at URLhttp://intl.jbc.org/cgi/content/abstract/254/12/5357
P698PubMed publication ID447655

P2093author name stringT. S. Edgington
E. F. Plow
G. A. Marguerie
P433issue12
P407language of work or nameEnglishQ1860
P1104number of pages7
P304page(s)5357-5363
P577publication date1979-06-01
1979-06-25
P1433published inJournal of Biological ChemistryQ867727
P1476titleHuman platelets possess an inducible and saturable receptor specific for fibrinogen
P478volume254

Reverse relations

cites work (P2860)
Q33821916A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa
Q35807990A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein
Q42161870A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom
Q37004238A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors
Q36529569Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells
Q36233226Affinity modulation of integrin alpha 5 beta 1: regulation of the functional response by soluble fibronectin
Q36772797Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor
Q73295898Affinity of Fibrinogen Binding to Platelet Membrane Glycoprotein IIb/IIIa Increases with RGDS and gamma Chain Fibrinogen Peptide Hybrid
Q34313515Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation
Q36529134An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion
Q39989355Analysis of Fyn function in hemostasis and alphaIIbbeta3-integrin signaling
Q24561798Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation
Q37357899Bcr/Abl expression stimulates integrin function in hematopoietic cell lines
Q40919205Binding of fibrinogen to human monocytes
Q35593515Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa
Q41517642Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes
Q42861864Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins. Effects of lipids and temperature
Q40141187Characteristics of an ADP receptor mediating platelet activation
Q36426462Characterization of the 5'-flanking region for the human fibrinogen beta gene
Q42701284Comparative pharmacology of analogues of S‐nitroso‐N‐acetyl‐dl‐penicillamine on human platelets
Q37007168Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen
Q36985923Complex formation of platelet thrombospondin with fibrinogen
Q41146492Description of an in vitro angiogenesis model designed to test antiangiogenic molecules
Q36220809Differential structural requirements for fibrinogen binding to platelets and to endothelial cells
Q34543964Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia
Q34018917Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation
Q35585012Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon
Q34173198Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow
Q77763145Elucidation of a common structure of selective fibrinogen receptor antagonists
Q41438052Endocytosis by human platelets: metabolic and freeze-fracture studies
Q36232933Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets
Q34526333Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase
Q41563619Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL).
Q36524428Expression of the PlA2 allele of glycoprotein IIIa and its impact on platelet function.
Q40343677Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin
Q34554656Fibrin induces release of von Willebrand factor from endothelial cells
Q36316463Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro
Q36216126Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro.
Q37397492Fibrinogen mitogenic effect on hemopoietic cell lines: control via receptor modulation
Q35587275Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation
Q39800614Functional assay of antiplatelet drugs based on margination of platelets in flowing blood
Q37360713Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection
Q36218390Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets
Q36220256High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets
Q36348940Human platelet activation by C3a and C3a des-arg
Q37394914Immunologic relationship between platelet membrane glycoprotein GPIIb/IIIa and cell surface molecules expressed by a variety of cells
Q36299694Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline
Q37609861Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody
Q73254319Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction
Q37393216Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets
Q37011736Integrin αIIbβ3: from discovery to efficacious therapeutic target
Q34521582Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding
Q34624945Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation
Q41848646Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets
Q70988269Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG
Q42874602Interactions between platelet-surface glycoproteins. Identification of glycoproteins capable of binding to platelet surfaces
Q42981591Interactions of integrin GPIIb/IIIa-derived peptides with fibrinogen investigated by NMR spectroscopy
Q37026661Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody
Q24314835Isolation of the thrombospondin membrane receptor
Q37008359Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway
Q68585030Localization of adhesive proteins in two newly subdivided zones in electron-lucent matrix of human platelet alpha-granules
Q35836105Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses
Q49251166Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis
Q70159564Microenvironment changes of human blood platelet membranes associated with fibrinogen binding
Q34574739Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.
Q34600570Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction
Q34353018Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function
Q33476410Monocytes and platelets share the glycoproteins IIb and IIIa that are absent from both cells in Glanzmann's thrombasthenia type I
Q36232350Multiple functional forms of the integrin VLA-2 can be derived from a single alpha 2 cDNA clone: interconversion of forms induced by an anti-beta 1 antibody
Q36346490Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase
Q39476365Nephrotic syndrome: a platelet hyperaggregability state
Q72745713Optimal techniques for the immunocytochemical demonstration of?-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets
Q39506588Platelet activation in normo- and hyperlipoproteinemias
Q71234741Platelet aggregation is inhibited by phycolectins
Q33404652Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors
Q36053594Platelet glycoprotein IIb/IIIa blockade with tirofiban: effect on aggregation caused by P256, an antibody to human IIb/IIIa receptors
Q35832156Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets
Q33821754Platelets have more than one binding site for von Willebrand factor
Q41915162Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets
Q24318637Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C
Q41453134Redistribution of alpha-granules and their contents in thrombin-stimulated platelets
Q36211385Redistribution of the fibrinogen receptor of human platelets after surface activation
Q34615338Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons
Q73254326Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists
Q37294912Role of fibrinogen alpha and gamma chain sites in platelet aggregation
Q28118972Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia
Q35056329Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit
Q89554692Site-specific phosphorylation regulates the functions of kindlin-3 in a variety of cells
Q40146427Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia
Q37553472Synthesis of analogs of human platelet membrane glycoprotein IIb-IIIa complex by chicken peripheral blood thrombocytes
Q48089724Temperature effects on the activity, shape, and storage of platelets from 13-lined ground squirrels.
Q43735302Temporal aggregate size distributions from simulation of platelet aggregation and disaggregation
Q42160889Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa
Q33381441The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
Q37556824The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets
Q42540753The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.
Q35839049The effect of upstream platelet-fibrinogen interactions on downstream adhesion and activation
Q42153397The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element
Q35898379The human platelet fibrinogen receptor: clinical and therapeutic significance
Q42161875The inhibition of human platelet function by ganodermic acids
Q34111783The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms
Q71270172The platelet contacts during aggregation
Q41517769The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering
Q38156780The platelet fibrinogen receptor: from megakaryocyte to the mortuary
Q41904505The role of integrins in the maintenance of endothelial monolayer integrity
Q34182746The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress
Q36233524Thrombin adhesive properties: induction by plasmin and heparan sulfate
Q36356892Thrombin increases expression of fibronectin antigen on the platelet surface
Q36345711Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study
Q35816269Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets
Q35680201Using microcontact printing of fibrinogen to control surface-induced platelet adhesion and activation
Q40347050Vitronectin binds to activated human platelets and plays a role in platelet aggregation
Q70123739[Significance of the endothelium of the vascular wall for maintaining hemostasis]
Q24301146gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors
Q33478102von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease
Q34574601von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia

Search more.